Abstract:
OBJECTIVE:To investigate whether intravenously infused provokes migraine aura and migraine headache in migraine patients with aura. BACKGROUND:Migraine with aura has been associated with endothelial dysfunction and increased stroke risk. The initiating mechanism of migraine aura symptoms is not known. Experimental provocation of migraine headache using vasoactive peptides has provided tremendous advances in the understanding of migraine pathophysiology but substances that can induce migraine aura have not been identified. Endothelin-1 (ET-1), an endogenous, potent vasoconstrictor peptide released from the vascular endothelium, has been proposed to trigger migraine aura. This hypothesis is based on reports of increased plasma ET-1 levels early during the migraine attacks and the observation that ET-1 applied to the cortical surface potently induces the cortical spreading depolarization, the underlying electrophysiological phenomenon of migraine aura, in animals. Further, endothelial damage due to, for example, carotid puncture and vascular pathology is known to trigger aura episodes. METHODS:We investigated whether intravascular ET-1 would provoke migraine aura in patients. Using a two-way crossover, randomized, placebo-controlled, double-blind design, we infused high-dose (8 ng/kg/minutes for 20 minutes) intravenous ET-1 in patients with migraine with typical aura. The primary end-point was the difference in incidence of migraine aura between ET-1 and placebo. Experiments were carried out at a public tertiary headache center (Danish Headache Center, Rigshospitalet Glostrup, Denmark). RESULTS:Fourteen patients received intravenous ET-1. No patients reported migraine aura symptoms or migraine headache during or up to 24 hours following the ET-1 infusion. Four patients reported mild to moderate headache only on the ET-1 day, 3 patients reported moderate headache on the placebo day, and 1 patient reported mild headache on both days. No serious adverse events occurred during or after infusion. CONCLUSIONS:Provocation of migraine aura by procedures or conditions involving vascular irritation is unlikely to be mediated by ET-1.
journal_name
Headachejournal_title
Headacheauthors
Hougaard A,Younis S,Iljazi A,Sugimoto K,Ayata C,Ashina Mdoi
10.1111/head.13753subject
Has Abstractpub_date
2020-04-01 00:00:00pages
724-734issue
4eissn
0017-8748issn
1526-4610journal_volume
60pub_type
杂志文章相关文献
HEADACHE文献大全abstract:OBJECTIVE:To evaluate triptan use patterns in a large Israeli HMO district. BACKGROUND:Triptans, 5HT(1B/1D) agonists, provide an effective and safe relief of headache and accompanying symptoms during an acute migraine attack. METHOD:We retrospectively reviewed the computerized prescription filling data of 1498 patien...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00435.x
更新日期:2006-09-01 00:00:00
abstract:OBJECTIVE:To characterize adult patients with episodic migraine who achieved 100% response to galcanezumab treatment. BACKGROUND:Galcanezumab is a humanized monoclonal antibody that selectively binds to the calcitonin gene-related peptide (CGRP) and has demonstrated efficacy in reducing migraine headache days (MHD) in...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/head.13427
更新日期:2018-10-01 00:00:00
abstract::Forecasting how medicine will be practiced 50 years from now presents a challenge. While advances in technology will have a major impact, new cultural outlooks on physician professionalism and autonomy will have an even greater significance in daily practice. The current healthcare system is in crisis. As members of a...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01113.x
更新日期:2008-05-01 00:00:00
abstract:BACKGROUND:Headache is commonly reported in patients presenting with orofacial pain. It has only recently been demonstrated that headache-related disability is high in orofacial pain patients. Traumatic life events (TLEs) such as sexual abuse, physical abuse, and post-traumatic stress disorder (PTSD) are also common in...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01182.x
更新日期:2009-04-01 00:00:00
abstract::Objective - To briefly describe the history of and available data on anti-calcitonin gene-related peptide (CGRP) therapies for headache. Background - CGRP was proposed as a target for primary headache therapies. Translational research involved moving from delineating the relationships between CGRP and primary headache...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13379
更新日期:2018-11-01 00:00:00
abstract::This is a case report of a 15-year-old boy who developed benign intracranial hypertension after 3 weeks of levofloxacin intake. The headache, diplopia, and papilledema resolved within a week after levofloxacin was withdrawn. Physicians must be aware that quinolone antibiotics can potentially cause intracranial hyperte...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01212.x
更新日期:2009-02-01 00:00:00
abstract:OBJECTIVE:To assess the prevalence and risk factors for pediatric migraine with aura (MWA) among patients presenting to pediatric neurology clinics. BACKGROUND:Headache is a common complaint among children, and the prevalence of migraine is about 8%. Up to one third of adults with migraine report experiencing aura; ho...
journal_title:Headache
pub_type: 杂志文章,多中心研究
doi:10.1111/head.12741
更新日期:2016-01-01 00:00:00
abstract:OBJECTIVE:To examine the disability, health care resource utilization, and direct annual costs among patients with migraine, categorized according to the number of headache days experienced in the past month. BACKGROUND:Migraine exists on a continuum of different attack frequencies and associated levels of disability....
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13421
更新日期:2018-11-01 00:00:00
abstract::Several clinical and circulatory physiological observations indicate that the internal carotid artery (ICA) with proximal pial and orbital-periorbital branches, as well as external carotid vessels adjacent to the orbital region, are involved in the autonomic symptoms of an attack of cluster headache. Evidence is prese...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.1991.hed3105314.x
更新日期:1991-05-01 00:00:00
abstract:OBJECTIVES:In a randomized controlled trial extending over 6 months, we evaluated the effectiveness of acupuncture versus flunarizine in the prophylactic treatment of migraine without aura. METHODS:One hundred sixty women with migraines were randomly assigned to acupuncture treatment (group A, n = 80) or to an oral th...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1046/j.1526-4610.2002.02203.x
更新日期:2002-10-01 00:00:00
abstract:BACKGROUND:Basilar-type migraine (BM) is the most common migraine "variant," representing 3-19% of migraine in children.BMis characterized by attacks of dizziness, vertigo, visual disturbances, ataxia, and/or diplopia, followed by migraine headache. OBJECTIVE:The objective of this study is to assess the efficacy and s...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1111/j.1526-4610.2007.00867.x
更新日期:2007-11-01 00:00:00
abstract:BACKGROUND:It has been suggested that homocysteine (Hcy) and the 5'-10'-methylenetetrahydrofolate reductase (MTHFR) C677T variant are implicated in the pathogenesis of migraine. Homocysteine has the potential to damage endothelium and accelerate atherosclerosis. Genetic factors such as the MTHFR C677T polymorphism, and...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01484.x
更新日期:2010-01-01 00:00:00
abstract:OBJECTIVE:The objective of this study was to assess the clinical benefits of onabotulinumtoxinA (BOTOX®) treatment on the symptoms of cervical dystonia and the frequency, severity, and associated symptoms of migraine in patients with cervical dystonia and concurrent migraine. BACKGROUND:Botulinum toxin is established ...
journal_title:Headache
pub_type: 临床试验,杂志文章
doi:10.1111/j.1526-4610.2012.02164.x
更新日期:2012-09-01 00:00:00
abstract:BACKGROUND:MAP0004 is a novel orally inhaled formulation of dihydroergotamine mesylate (DHE) currently in development that has been clinically observed to provide rapid ( approximately 10 minutes) therapeutic levels of DHE but with lower rates of adverse effects (dizziness, nausea, and paresthesia) compared with intrav...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01510.x
更新日期:2009-11-01 00:00:00
abstract:BACKGROUND:The protein s100b indicates astrocytal damage as well as dysfunction of the blood-brain barrier (BBB), and neuron-specific enolase (NSE) is regarded as a marker for neuronal cell loss. Recently, s100b was shown to be a potentially useful marker for migraine in children. In this study, we investigated the lev...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01228.x
更新日期:2009-02-01 00:00:00
abstract:OBJECTIVES:To estimate the 1-year prevalence of headache, its repercussion and its association with the academic performance of university students. METHODS:Cross-sectional study. Three hundred eighty students were randomly selected out of the 1718, 90.5% of them were interviewed. A semi-structured interview, the Head...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2011.02012.x
更新日期:2011-11-01 00:00:00
abstract:OBJECTIVE:To assess the acute treatment of pregnant women presenting to a hospital with migraine. BACKGROUND:Migraine is a common problem in pregnancy; however, migraine treatment is challenging in pregnant women for fears of medication teratogenicity and lack of data in this population. To date, no study has directly...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13434
更新日期:2019-02-01 00:00:00
abstract:OBJECTIVE:To evaluate the effect of different migraine prophylaxis medications on subject responsiveness to almotriptan. BACKGROUND:There is evidence supporting an increase of responsiveness of symptomatic medications for migraine attacks by some prophylactic treatments although this has not been probed. METHODS:A to...
journal_title:Headache
pub_type: 临床试验,杂志文章
doi:10.1111/j.1526-4610.2009.01491.x
更新日期:2009-10-01 00:00:00
abstract:OBJECTIVE:This study compared clinical manifestations and audiovestibular function tests among subjects of basilar-type migraine (BtM), definite and probable migrainous vertigo (dMV and pMV), in order to investigate the relationship between them. BACKGROUND:Various diagnostic criteria such as BtM, dMV, and pMV have be...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01283.x
更新日期:2009-03-01 00:00:00
abstract:BACKGROUND:Using standard quality of life and disability measures may not accurately capture these constructs in specific health populations such as headache patients. Modifying the wording of standard measures such as the Short-Form 36 (SF-36) should be considered in order to make them more applicable to specific pati...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2012.02156.x
更新日期:2012-06-01 00:00:00
abstract:OBJECTIVE:To evaluate the efficacy of ubrogepant on patient-reported functional disability, satisfaction with study medication, and global impression of change. BACKGROUND:Ubrogepant is a small-molecule, oral calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine. In 2 phase ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13766
更新日期:2020-04-01 00:00:00
abstract:OBJECTIVE:To describe the pharmacokinetic and safety profiles of sumatriptan 85 mg formulated with RT Technology (RT) and naproxen sodium 500 mg in a fixed-dose combination tablet (sumatriptan/naproxen sodium) that targets both serotonergic dysmodulation and inflammation in migraine. METHODS:Six open-label, crossover ...
journal_title:Headache
pub_type: 临床试验,杂志文章
doi:10.1111/j.1526-4610.2009.01606.x
更新日期:2010-03-01 00:00:00
abstract:OBJECTIVE:To test whether chronic headache (>3 days/week) is more prevalent than episodic headache (<3 days/week) in patients with a previous history of significant head trauma. METHOD:We included 903 consecutive patients referred to a specialist center for headache during a period of 2 years. As the main parameter, w...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2003.03010.x
更新日期:2003-01-01 00:00:00
abstract:OBJECTIVE:Previous attempts to develop a pragmatic human model for testing new anti-migraine drugs, have failed. Calcitonin gene-related peptide (CGRP) induces a mild headache in healthy volunteers and migraine-like headache in migraine patients. The induced headache must respond to already established migraine treatme...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13747
更新日期:2020-04-01 00:00:00
abstract::The ergot alkaloids are a family of chemical entities that have many pharmacologic effects. Their diversity results from their interaction with multiple receptors, their variable receptor affinity and intrinsic activity, and their variable organ-specific receptor access. Ergotamine tartrate (ET) was one of the first e...
journal_title:Headache
pub_type: 杂志文章,评审
doi:
更新日期:1997-01-01 00:00:00
abstract:OBJECTIVE:This post hoc study investigated the relationship between patient response in terms of migraine headache day reduction and patient-reported outcomes of health-related quality of life (HRQoL) and disability categories. BACKGROUND:Migraine causes considerable disease-related disability and negatively impacts H...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.14013
更新日期:2020-11-01 00:00:00
abstract::This work assesses the differences in the thermographic findings in the craniofacial and neck areas between normal individuals and patients with craniofacial pain or headache, and investigates the influence of muscle contraction on such findings. Thermographic records were taken in 10 healthy subjects and 47 patients ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1990.hed3008497.x
更新日期:1990-07-01 00:00:00
abstract:OBJECTIVE:To address the need for a rigorous, direct comparison of prescription and over-the-counter (OTC) migraine drugs and to expand the database on early treatment of migraine. BACKGROUND:Most people who experience migraine use OTC medications to treat their symptoms, but no head-to-head clinical trials comparing ...
journal_title:Headache
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1111/j.1526-4610.2005.05177.x
更新日期:2005-09-01 00:00:00
abstract:BACKGROUND:Despite the high level of individual and societal burden resulting from headache disorders, the National Institutes of Health (NIH) has funded relatively little research on these disorders. OBJECTIVE:The objective of this study was to define current patterns of NIH funding of research on headache disorders....
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01323.x
更新日期:2009-02-01 00:00:00
abstract:BACKGROUND:The pathophysiology of chronic migraine (CM) is not fully understood. We aimed to examine transcranial magnetic stimulation (TMS) indices of cortical excitability in patients with CM and also performed PET studies to ascertain if there were any areas of activation and inhibition for possible correlation. ME...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2007.00853.x
更新日期:2007-07-01 00:00:00